| HOME >> BIOLOGY >> TECHNOLOGY |
Commitments
Stockholders' equity:
Preferred stock, $0.00004 par value;
10,000 shares authorized; no shares issued
and outstanding - -
Common stock, $0.00004 par value; 150,000
shares authorized; 40,778 and 31,419 shares
issued and outstanding at December 31,
2007 and December 31, 2006, respectively 2 1
Additional paid-in capital 184,014 163,482
Stock subscription receivables - (27)
Accumulated other comprehensive income 5,895 5,869
Accumulated deficit (164,933) (144,807)
Total stockholders equity 24,978 24,518
Total liabilities and stockholders' equity $56,252 $51,172
Micromet, Inc.
Condensed Consolidated Statements of Operations
(In thousands, except per share amounts)
Three Months Ended Year Ended
December 31, December 31,
2007 2006 2007 2006
Revenues
Collaboration agreements $6,751 $12,596 $17,366 $25,449
License fees and other 234 1,211 1,018 2,134
Total revenues 6,985 13,807 18,384 27,583
Operating expenses
Research and development 9,471 7,385 29,191 28,252
In-process research and
development - - - 20,890
General and administrative 3,590 3,495 14,430 12,012
Total operating expenses 13,061 10,880 43,621
'/>"/>
| SOURCE Micromet, Inc. Copyright©2008 PR Newswire. All rights reserved |